Page last updated: 2024-10-31

midazolam and Dysphagia

midazolam has been researched along with Dysphagia in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Balko, RA1
Katzka, DA1
Murray, JA1
Alexander, JA1
Mara, KC1
Ravi, K1
Cierpka, K1
Rickenbacher, P1
Burckhardt, D1
Lüscher, TF1

Other Studies

2 other studies available for midazolam and Dysphagia

ArticleYear
Same-day opioid administration in opiate naïve patients is not associated with opioid-induced esophageal dysfunction (OIED).
    Neurogastroenterology and motility, 2021, Volume: 33, Issue:5

    Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Intravenous; Chest Pain; Conscious Sedation; Deglutiti

2021
[Subjective tolerance to transesophageal echocardiography].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1994, Mar-15, Volume: 83, Issue:11

    Topics: Adult; Age Factors; Aged; Deglutition Disorders; Echocardiography, Transesophageal; Female; Hiccup;

1994